Register Interest

Eleusian Biosciences Corp

Eleusian Biosciences Corp., a Toronto based company, is focused on development of therapeutics for multiple pathological psychological diseases based on psilocybin plus N-Acetylcysteine(NAC) compounds.

Eleusian is collaborating with a multidisciplinary team of scientists and physicians at the University of Miami to develop effective therapeutics for the treatment of mTBI (mild traumatic brain injury/concussion) with PTSD or PTSD alone based on Psilocybin (the active ingredient of psychedelic mushrooms) and N-Acetylcysteine(NAC).